Inclusion criteria:
The weight range of participating candidates should be between 60-100 kg.
Candidates should be healthy in terms of physical examination, ECG and the following laboratory tests: Hemoglobin, Hematocrit, Red and White Blood Count, MCV (Mean Body Volume), MCH (Mean Body Hemoglobin), Routine Urinalysis, Total Cholesterol, Triglyceride, Total Proteins, albumin, uric acid, total bilirubin, alkaline phosphatase, gamma glutamyl transpeptidase (γ-GT), aspartate aminotransferase (AST), alanine aminotransferase (ALT), urea, creatinine and fasting blood glucose.
Volunteers who have agreed to an informed consent form.
All candidates should not consume caffeine-containing drinks and chocolate during two days before the prescription, and this restriction must be followed until the last blood draw.
Exclusion criteria:
History of allergic or adverse reaction to Anagrelide or any similar product
Volunteers with blood pressure less than 60/90 mm Hg or higher than 90/140 mm Hg
Individuals who donated whole blood or blood components within 2 months within 2 weeks prior to the first dose of the study product(s)
Smokers